| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/DMRR.390 |
| P698 | PubMed publication ID | 12879403 |
| P50 | author | Stefano Del Prato | Q41467287 |
| P2093 | author name string | Volpe L | |
| Di Cianni G | |||
| Lencioni C | |||
| Miccoli R | |||
| P2860 | cites work | Role of cAMP in upregulation of insulin secretion during the adaptation of islets of Langerhans to pregnancy | Q77191773 |
| Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus | Q77326032 | ||
| Plasma leptin levels in newborns from normal and diabetic mothers | Q77531145 | ||
| The effects of treatment on the direct costs of diabetes | Q77671377 | ||
| Positional cloning of the mouse obese gene and its human homologue | Q22251285 | ||
| Longitudinal study of carbohydrate metabolism in healthy obese pregnant women | Q73666304 | ||
| Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans | Q73677617 | ||
| Effect of estradiol on serum triglyceride lipoprotein levels and fatty acid composition in castrated rats | Q73957395 | ||
| Growth promoting effects of human placental lactogen during early organogenesis: a link to insulin-like growth factors | Q74243018 | ||
| Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance | Q33588931 | ||
| Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes mellitus | Q33850130 | ||
| The infant of the woman with gestational diabetes mellitus | Q33850145 | ||
| The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development | Q33897371 | ||
| Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo | Q33898881 | ||
| Obesity and pregnancy: complications and cost | Q33911797 | ||
| Protein metabolism in pregnancy | Q33911800 | ||
| Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus | Q33911806 | ||
| Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks | Q34301257 | ||
| Phasic insulin release and metabolic regulation in type 2 diabetes. | Q34508759 | ||
| Hyperglucagonemia and insulin-mediated glucose metabolism | Q34560371 | ||
| Insulin resistance in type 2 diabetes: role of fatty acids | Q34580981 | ||
| Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project | Q34720852 | ||
| Biphasic effects of maternal metabolism on fetal growth. Quintessential expression of fuel-mediated teratogenesis | Q36812544 | ||
| Leptin in human reproduction: serum leptin levels in pregnant and lactating women | Q38348913 | ||
| Adjustments in energy expenditure and substrate utilization during late pregnancy and lactation | Q38528242 | ||
| Diabetes in pregnancy 1985. | Q39730138 | ||
| Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women | Q40593877 | ||
| Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes | Q40797942 | ||
| Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women | Q40846655 | ||
| Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy | Q40870207 | ||
| Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing | Q40986651 | ||
| Abnormalities of islet B-cell function, insulin action, and fat distribution in women with histories of gestational diabetes: relationship to obesity | Q41370448 | ||
| Impact of maternal euglycemia on fetal outcome in diabetic pregnancy | Q41531741 | ||
| Malformations in infants of diabetic mothers occur before the seventh gestational week. Implications for treatment | Q41558586 | ||
| Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes | Q41618928 | ||
| Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregn | Q42489803 | ||
| Increased plasma leptin in gestational diabetes. | Q42501684 | ||
| Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters | Q42502926 | ||
| Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus | Q42504824 | ||
| Adipocyte insulin receptor binding and lipogenesis at term in normal pregnancy | Q42513365 | ||
| Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM. | Q42525273 | ||
| Impaired insulin receptor binding and postbinding defects of adipocytes from normal and diabetic pregnant women | Q42528481 | ||
| Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus | Q43702115 | ||
| Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. | Q43953703 | ||
| Placental GH, IGF-I, IGF-binding protein-1, and leptin during a glucose challenge test in pregnant women: relation with maternal body weight, glucose tolerance, and birth weight | Q44018197 | ||
| TNF-alpha is a predictor of insulin resistance in human pregnancy | Q44043228 | ||
| Congenital Susceptibility to NIDDM: Role of Intrauterine Environment | Q44047223 | ||
| Insulin resistance syndrome in women with prior history of gestational diabetes mellitus | Q44055166 | ||
| Prevalence and etiology of respiratory distress in infants of diabetic mothers: predictive value of fetal lung maturation tests | Q44631236 | ||
| Hypertriglyceridemia during late pregnancy is associated with the formation of small dense low-density lipoproteins and the presence of large buoyant high-density lipoproteins. | Q45945512 | ||
| Unusual high-density lipoprotein subclass distribution during late pregnancy | Q46147827 | ||
| Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus | Q46451754 | ||
| Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy | Q46660612 | ||
| IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants | Q47186636 | ||
| Prediction of infant birth weight by GDM screening tests. Importance of plasma triglyceride | Q47404217 | ||
| Elevation of plasma leptin levels during pregnancy in normal and diabetic women | Q47832821 | ||
| Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy | Q48020358 | ||
| Membrane glycoprotein PC-1 and insulin resistance. | Q48021584 | ||
| Glucose utilization rates and insulin sensitivity in vivo in tissues of virgin and pregnant rats | Q48381710 | ||
| Correlations between antepartum maternal metabolism and intelligence of offspring | Q48653793 | ||
| Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. | Q51038774 | ||
| Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. | Q51556341 | ||
| Effects of overexpression of human GLUT4 gene on maternal diabetes and fetal growth in spontaneous gestational diabetic C57BLKS/J Lepr(db/+) mice. | Q51563482 | ||
| Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes. | Q51570864 | ||
| Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes. | Q51576215 | ||
| Increased molar proinsulin-to-insulin ratio in women with previous gestational diabetes does not predict later impairment of glucose tolerance. | Q51583847 | ||
| Excessive secretion of insulin precursors characterizes and predicts gestational diabetes. | Q51586878 | ||
| A longitudinal study of plasma insulin and glucagon in women with previous gestational diabetes. | Q51588612 | ||
| Progesterone administration induced impairment of insulin suppression of hepatic glucose production. | Q51593880 | ||
| Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal women. | Q51594762 | ||
| Metabolism of urea and glucose in normal and diabetic pregnancy. | Q51650152 | ||
| Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids. | Q51659128 | ||
| Adaptation of pancreatic islet B-cells during the last third of pregnancy: regulation of B-cell function and proliferation by lactogenic hormones in rats. | Q52173911 | ||
| Decreased Expression of the GLUT4 Glucose Transporter Protein in Adipose Tissue During Pregnancy | Q54174092 | ||
| Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women | Q54284181 | ||
| Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. | Q54327144 | ||
| Role of gestational hormones in the induction of insulin resistance. | Q54378876 | ||
| Insulin action during pregnancy. Studies with the euglycemic clamp technique. | Q54452533 | ||
| Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes | Q57919802 | ||
| Prevalence and Predictive Value of Islet Cell Antibodies and Insulin Autoantibodies in Women with Gestational Diabetes | Q59488079 | ||
| The epidemiology of diabetes and pregnancy in the U.S., 1988 | Q64134933 | ||
| Follow-Up of Women With Previous GDM: Insulin, C-Peptide, and Proinsulin Responses to Oral Glucose Load | Q67773971 | ||
| Effects of prolactin and glycosylated prolactin on (pro)insulin synthesis and insulin release from cultured rat pancreatic islets | Q68925276 | ||
| Effect of prolactin versus growth hormone on islet function and the importance of using homologous mammosomatotropic hormones | Q69541192 | ||
| Erythropoiesis in infants of diabetic mothers | Q70007355 | ||
| Calcium metabolism in diabetic mother, fetus, and newborn infant | Q70249061 | ||
| Effects of steroid and lactogenic hormones on islets of Langerhans: a new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy | Q70492740 | ||
| Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy | Q70541829 | ||
| Glucokinase, hexokinase, glucose transporter 2, and glucose metabolism in islets during pregnancy and prolactin-treated islets in vitro: mechanisms for long term up-regulation of islets | Q71033080 | ||
| Magnesium, the mimic/antagonist to calcium | Q71306698 | ||
| Assessment of Gestational Age and Development at Birth | Q71433523 | ||
| Lipid levels in former gestational diabetic mothers | Q71829379 | ||
| Congenital anomalies and diabetes in the Prima Indians of Arizona | Q72412638 | ||
| Changes in cholesteryl ester transfer protein activity during normal gestation and postpartum | Q72497160 | ||
| Defects in insulin signal transduction in liver and muscle of pregnant rats | Q73108242 | ||
| Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis | Q73114832 | ||
| Detection of placental growth hormone variant and chorionic somatomammotropin-L RNA expression in normal and diabetic pregnancy by reverse transcriptase-polymerase chain reaction | Q73320492 | ||
| Hormonal parameters in gestational diabetes mellitus during the third trimester: high glucagon levels | Q73442285 | ||
| Growth patterns of large-for-gestational-age and appropriate-for-gestational-age infants of gestational diabetic mothers and control mothers at age 1 year | Q73459007 | ||
| P433 | issue | 4 | |
| P921 | main subject | gestational diabetes | Q126691 |
| P304 | page(s) | 259-270 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
| P1476 | title | Intermediate metabolism in normal pregnancy and in gestational diabetes | |
| P478 | volume | 19 |
| Q28943281 | A genome-wide association study of gestational diabetes mellitus in Korean women |
| Q34063116 | A holobiont birth narrative: the epigenetic transmission of the human microbiome |
| Q53764642 | A novel insulin sensitivity index particularly suitable to measure insulin sensitivity during gestation. |
| Q43651796 | A past medical history of gestational diabetes: its medical significance and its dental implications |
| Q64066735 | Adverse pregnancy outcomes and long-term risk of maternal renal disease: a systematic review and meta-analysis protocol |
| Q36444907 | Adverse pregnancy outcomes in women with diabetes |
| Q37441548 | An Unbiased Lipidomics Approach Identifies Early Second Trimester Lipids Predictive of Maternal Glycemic Traits and Gestational Diabetes Mellitus. |
| Q37198235 | Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice |
| Q90313517 | Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice |
| Q35613933 | Attenuating type 2 diabetes with postpartum interventions following gestational diabetes mellitus |
| Q36896473 | Carbohydrate Content in the GDM Diet: Two Views: View 1: Nutrition Therapy in Gestational Diabetes: The Case for Complex Carbohydrates |
| Q55209582 | Circulating MicroRNAs as Biomarkers of Gestational Diabetes Mellitus: Updates and Perspectives. |
| Q92860432 | Circulating miR-330-3p in Late Pregnancy is Associated with Pregnancy Outcomes Among Lean Women with GDM |
| Q49192585 | Circulating microRNA (miRNA) Expression Profiling in Plasma of Patients with Gestational Diabetes Mellitus Reveals Upregulation of miRNA miR-330-3p |
| Q34675585 | Correlation between maternal weight and insulin resistance in second half of pregnancy |
| Q45142903 | Decreased contraction-stimulated glucose transport in isolated epitrochlearis muscles of pregnant rats |
| Q47661190 | Decreased insulin secretion in pregnant rats fed a low protein diet |
| Q35234334 | Dynamic efficiency of the human intestinal microbiota |
| Q35853171 | Early Pregnancy Maternal Lipid Profiles and the Risk of Gestational Diabetes Mellitus Stratified for Body Mass Index |
| Q60934993 | Early Subclinical Atherosclerosis in Gestational Diabetes: The Predictive Role of Routine Biomarkers and Nutrigenetic Variants |
| Q37199572 | Effects of dietary fat subtypes on glucose homeostasis during pregnancy in rats |
| Q39763603 | Elevated insulin sensitivity and β-cell function during pregnancy in mothers of growth-restricted newborns |
| Q37724225 | Epigenetic signatures of gestational diabetes mellitus on cord blood methylation. |
| Q37267837 | Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies |
| Q36635518 | Fetal programming and cardiovascular pathology |
| Q89677270 | Fetuin-A and fetal growth in gestational diabetes mellitus |
| Q36528807 | Finding genetic risk factors of gestational diabetes |
| Q28291029 | Genetic variants and the risk of gestational diabetes mellitus: a systematic review |
| Q38709349 | Genetics of Gestational Diabetes Mellitus and Maternal Metabolism |
| Q37589850 | Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy |
| Q28067405 | Gestational Diabetes Mellitus and Future Cardiovascular Risk: An Update |
| Q91644241 | Gestational diabetes mellitus in association with macrosomia in Iran: a meta-analysis |
| Q30417691 | Gestational diabetes mellitus: a positive predictor of type 2 diabetes? |
| Q37678419 | Gestational diabetes mellitus: an opportunity to prevent type 2 diabetes and cardiovascular disease in young women |
| Q39173703 | Gestational diabetes mellitus: an updated overview. |
| Q38875540 | Gestational diabetes mellitus: does an effective prevention strategy exist? |
| Q37030452 | Gestational diabetes, inflammation, and late vascular disease |
| Q49908337 | Gestational retinal microvasculature and the risk of 5 year postpartum abnormal glucose metabolism. |
| Q37351633 | Glucose Fluctuations during Gestation: An Additional Tool for Monitoring Pregnancy Complicated by Diabetes |
| Q64375772 | Hepatic hexokinase domain containing 1 (HKDC1) improves whole body glucose tolerance and insulin sensitivity in pregnant mice |
| Q36421887 | Host remodeling of the gut microbiome and metabolic changes during pregnancy |
| Q90676716 | Impact of contraception and IVF hormones on metabolic, endocrine, and inflammatory status |
| Q27026752 | Insulin analogues in the treatment of diabetes in pregnancy |
| Q51463316 | Insulin resistance has no impact on ghrelin suppression in pregnancy. |
| Q36092959 | Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool? |
| Q38605892 | Ketoacidosis in diabetic pregnancy |
| Q90401084 | Label-Free Metabolic Classification of Single Cells in Droplets Using the Phasor Approach to Fluorescence Lifetime Imaging Microscopy |
| Q89636668 | Lactation Duration and Long-term Risk for Incident Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus |
| Q33687575 | Late cardiovascular consequences of gestational diabetes mellitus |
| Q92257863 | Low-Carbohydrate Diets for Gestational Diabetes |
| Q91592451 | Maternal Lipids and Fetal Overgrowth: Making Fat from Fat |
| Q92164399 | Maternal Omega-3 Nutrition, Placental Transfer and Fetal Brain Development in Gestational Diabetes and Preeclampsia |
| Q26865194 | Maternal cardiac metabolism in pregnancy |
| Q47183111 | Maternal educational level and the risk of persistent post-partum glucose metabolism disorders in women with gestational diabetes mellitus |
| Q47219591 | Maternal metabolic adaptations to pregnancy among young women in Cebu, Philippines |
| Q77792823 | Maternal urinary phthalate metabolites in relation to gestational diabetes and glucose intolerance during pregnancy |
| Q34430295 | Meta-analysis of the relationship between common type 2 diabetes risk gene variants with gestational diabetes mellitus |
| Q94566969 | Metabolic changes during pregnancy in glucose-intolerant NZO mice: A polygenic model with prediabetic metabolism |
| Q46769025 | Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. |
| Q35925707 | Monitoring blood glucose levels in female mink during the reproductive cycle: 1. Prevention of hyperglycemia during the nursing period |
| Q35925711 | Monitoring blood glucose levels in female mink during the reproductive cycle: 2. Effects of short-term fish oil, chromium picolinate, and acetylsalicylic acid supplementation during late lactation. |
| Q36926481 | New insights into gestational glucose metabolism: lessons learned from 21st century approaches |
| Q57059514 | Normal pregnancy induced glucose metabolic stress in a longitudinal cohort of healthy women: Novel insights generated from a urine metabolomics study |
| Q53693108 | Nutrition therapy within and beyond gestational diabetes. |
| Q48238530 | Postpartum glucose intolerance: an updated overview. |
| Q34823757 | Pre-eclampsia is associated with, and preceded by, hypertriglyceridaemia: a meta-analysis |
| Q93109023 | Precision Nutrition and the Microbiome Part II: Potential Opportunities and Pathways to Commercialisation |
| Q51314763 | Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices. |
| Q83957118 | Pregnancy issues in inherited metabolic disorders |
| Q91607245 | Pregnancy-associated cardiac dysfunction and the regulatory role of microRNAs |
| Q36926808 | Proximity to Delivery Alters Insulin Sensitivity and Glucose Metabolism in Pregnant Mice |
| Q35992912 | Relationship between lipid and lipoprotein metabolism in trimesters of pregnancy in Nigerian women: Is pregnancy a risk factor? |
| Q33944749 | Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsia |
| Q47919282 | Short- and long-term consequences for offspring exposed to maternal diabetes: a review |
| Q58316252 | The Pathobiology of Diabetes Mellitus |
| Q58114519 | The Pathophysiology of Gestational Diabetes Mellitus |
| Q89551831 | The Role of Dietary Carbohydrates in Gestational Diabetes |
| Q38820418 | The complex metabolism of trimethylamine in humans: endogenous and exogenous sources. |
| Q37127656 | The management of pregnancy in maple syrup urine disease: experience with two patients |
| Q53731990 | The rs10229583 polymorphism near paired box gene 4 is associated with gestational diabetes mellitus in Chinese women. |
| Q57688911 | Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews |
| Q90231163 | Urinary metabolomics reveals novel interactions between metal exposure and amino acid metabolic stress during pregnancy |
| Q26779412 | Use of Insulin Lispro Protamine Suspension in Pregnancy |
Search more.